NO2833973T3 - - Google Patents
Info
- Publication number
- NO2833973T3 NO2833973T3 NO13728551A NO13728551A NO2833973T3 NO 2833973 T3 NO2833973 T3 NO 2833973T3 NO 13728551 A NO13728551 A NO 13728551A NO 13728551 A NO13728551 A NO 13728551A NO 2833973 T3 NO2833973 T3 NO 2833973T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161506092P | 2011-07-09 | 2011-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2833973T3 true NO2833973T3 (pt) | 2018-02-10 |
Family
ID=47438792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO13728551A NO2833973T3 (pt) | 2011-07-09 | 2013-04-05 |
Country Status (14)
| Country | Link |
|---|---|
| US (6) | US10702485B2 (pt) |
| EP (2) | EP3272339A1 (pt) |
| CY (1) | CY1119597T1 (pt) |
| DK (1) | DK2729134T3 (pt) |
| ES (1) | ES2650368T3 (pt) |
| HR (1) | HRP20171743T1 (pt) |
| HU (1) | HUE037341T2 (pt) |
| LT (1) | LT2729134T (pt) |
| NO (1) | NO2833973T3 (pt) |
| PL (1) | PL2729134T3 (pt) |
| PT (1) | PT2729134T (pt) |
| RS (1) | RS56570B1 (pt) |
| SI (1) | SI2729134T1 (pt) |
| WO (1) | WO2013009666A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10702485B2 (en) | 2011-07-09 | 2020-07-07 | Syntrix Biosystems Inc. | Compositions and methods for overcoming resistance to tramadol |
| CA2942638A1 (en) | 2013-03-15 | 2014-09-18 | Demerx, Inc. | Method for noribogaine treatment of addiction in patients on methadone |
| DE102013009114A1 (de) * | 2013-05-29 | 2014-12-04 | Franz Gerstheimer | Pharmazeutische Zusammensetzung zur Überwindung von Metabolisierungsproblemen |
| US9561232B2 (en) | 2014-02-18 | 2017-02-07 | Demerx, Inc. | Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use |
| US9591978B2 (en) | 2014-03-13 | 2017-03-14 | Demerx, Inc. | Methods and compositions for pre-screening patients for treatment with noribogaine |
| EP2922348A1 (en) * | 2014-03-21 | 2015-09-23 | Alcatel Lucent | Network configuration |
| US9549935B2 (en) | 2014-07-14 | 2017-01-24 | Demerx, Inc. | Methods and compositions for treating migraines using noribogaine |
| ES2867174T3 (es) | 2014-11-26 | 2021-10-20 | Demerx Inc | Métodos y composiciones para potenciar la acción de analgésicos opioides mediante el uso de alcaloides de iboga |
| CA3024081A1 (en) * | 2015-05-11 | 2016-11-17 | Demerx, Inc. | Methods for treatment of opioid dependency and withdrawal using noribogaine |
| US11000488B2 (en) * | 2019-03-22 | 2021-05-11 | Syntrix Biosystems Inc. | Treating pain using desmetramadol |
| CN113861048A (zh) * | 2020-06-30 | 2021-12-31 | 南京诺瑞特医药科技有限公司 | 去甲曲马多的盐及其用途 |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652589A (en) | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4014334A (en) | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
| US4058122A (en) | 1976-02-02 | 1977-11-15 | Alza Corporation | Osmotic system with laminated wall formed of different materials |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
| GB8626098D0 (en) | 1986-10-31 | 1986-12-03 | Euro Celtique Sa | Controlled release hydromorphone composition |
| US5023083A (en) * | 1987-09-23 | 1991-06-11 | William Drell | Azarbine composition |
| KR100243956B1 (ko) | 1991-09-06 | 2000-03-02 | 랄프 알. 팔로 | 트라마돌 물질 및 아세트아미노펜을 포함하는 통증 치료용 약제학적 조성물 |
| AU657351B2 (en) | 1991-09-06 | 1995-03-09 | Mcneilab, Inc. | Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use |
| US5516803A (en) | 1991-10-30 | 1996-05-14 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| US5968551A (en) | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| GB9203689D0 (en) | 1992-02-20 | 1992-04-08 | Euro Celtique Sa | Pharmaceutical composition |
| US5292534A (en) | 1992-03-25 | 1994-03-08 | Valentine Enterprises, Inc. | Sustained release composition and method utilizing xanthan gum and an active ingredient |
| IL119660A (en) | 1993-05-10 | 2002-09-12 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
| US6017963A (en) | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
| DE19601744C2 (de) | 1996-01-19 | 1998-04-16 | Gruenenthal Gmbh | Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol |
| AU3290397A (en) * | 1996-06-10 | 1998-01-07 | Depomed, Inc. | Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
| DE19712398A1 (de) | 1997-03-25 | 1998-10-01 | Gruenenthal Gmbh | Orale Anwendung von (+)-0-Demethyltramadol als Schmerzmittel |
| EP1003476B1 (en) * | 1997-08-11 | 2004-12-22 | ALZA Corporation | Prolonged release active agent dosage form adapted for gastric retention |
| US6245357B1 (en) | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form |
| US6090411A (en) | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
| US6096341A (en) | 1998-10-30 | 2000-08-01 | Pharma Pass Llc | Delayed release tablet of bupropion hydrochloride |
| ES2141688B1 (es) | 1998-11-06 | 2001-02-01 | Vita Invest Sa | Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. |
| US6387956B1 (en) | 1999-03-24 | 2002-05-14 | University Of Cincinnati | Methods of treating obsessive-compulsive spectrum disorders |
| WO2001013904A2 (en) | 1999-08-20 | 2001-03-01 | Ortho-Mcneil Pharmaceutical, Inc. | Composition comprising a tramadol material and an anticonvulsant drug |
| DE19940740A1 (de) | 1999-08-31 | 2001-03-01 | Gruenenthal Gmbh | Pharmazeutische Salze |
| DE19940944B4 (de) | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
| PE20010623A1 (es) | 1999-10-05 | 2001-07-07 | Gruenenthal Chemie | Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria |
| US6339105B1 (en) | 1999-10-12 | 2002-01-15 | Ortho-Mcneil Pharmaceutical, Inc. | Analgesic regimen |
| AU1164601A (en) | 1999-11-09 | 2001-06-06 | Darwin Discovery Limited | Therapeutic use and formulation |
| ES2160534B1 (es) | 1999-12-30 | 2002-04-16 | Vita Invest Sa | Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo. |
| US6326404B1 (en) | 2000-02-21 | 2001-12-04 | Gruenenthal Gmbh | Use of O-desmethyl-N-mono-desmethyl-tramadol |
| US6720003B2 (en) * | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
| DE10108122A1 (de) * | 2001-02-21 | 2002-10-02 | Gruenenthal Gmbh | Arzneimittel auf Basis von Tramadol |
| DE10108123A1 (de) | 2001-02-21 | 2002-10-02 | Gruenenthal Gmbh | Wirkstoffkombination |
| EP1397126B9 (en) | 2001-03-16 | 2007-02-21 | DMI Biosciences, Inc. | Use of tramadol for delaying ejaculation |
| TWI259836B (en) * | 2001-04-12 | 2006-08-11 | Astrazeneca Ab | Modified release formulation suitable for antiarrhythmic compounds |
| WO2002090994A2 (en) | 2001-05-07 | 2002-11-14 | Mcgill University | Individualization of therapy with analgesics |
| WO2003048113A1 (en) | 2001-11-30 | 2003-06-12 | Sepracor Inc. | Tramadol analogs and uses thereof |
| MXPA05006210A (es) | 2002-12-13 | 2005-08-19 | Cilag Ag | Preparaciones de liberacion controlada que comprenden tramadol y topiramato. |
| US20040248979A1 (en) * | 2003-06-03 | 2004-12-09 | Dynogen Pharmaceuticals, Inc. | Method of treating lower urinary tract disorders |
| US7125848B2 (en) | 2003-06-13 | 2006-10-24 | Dynogen Pharmaceuticals, Inc. | Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators |
| DE10332486A1 (de) | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung akuter Schmerzen |
| DE10338544B4 (de) * | 2003-08-19 | 2017-08-31 | Janssen Pharmaceutica N.V. | Buccale Formulierungen des Galanthamins und deren Anwendungen |
| US20090082466A1 (en) | 2006-01-27 | 2009-03-26 | Najib Babul | Abuse Resistant and Extended Release Formulations and Method of Use Thereof |
| WO2007056142A2 (en) * | 2005-11-02 | 2007-05-18 | Theraquest Biosciences, Llc | Methods of preventing the serotonin syndrome and compositions for use therefor |
| WO2007114376A1 (ja) | 2006-03-30 | 2007-10-11 | Nippon Zoki Pharmaceutical Co., Ltd. | 固形医薬製剤 |
| JP2009535409A (ja) | 2006-05-03 | 2009-10-01 | コーワ ファーマシューティカルズ アメリカ，インコーポレイティド | 即効性ジクロフェナク−オピオイド組成物に基づく急性疼痛医薬 |
| EP2203166B1 (en) | 2007-10-16 | 2015-05-06 | Paladin Labs Inc. | Bilayer composition for the sustained release of acetaminophen and tramadol |
| JP5651818B2 (ja) | 2007-12-17 | 2015-01-14 | パラディン ラブス インコーポレーテッド | 誤用を防止するための放出制御製剤 |
| US8372432B2 (en) | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| ES2525005T3 (es) | 2008-03-21 | 2014-12-16 | Mylan Pharmaceuticals, Inc. | Formulación de liberación prolongada que contiene una cera |
| EP2362768B1 (en) | 2008-10-27 | 2016-04-20 | Alza Corporation | Extended release oral acetaminophen/tramadol dosage form |
| AU2009332963B2 (en) | 2008-12-31 | 2015-02-05 | Upsher-Smith Laboratories, Llc | Opioid-containing oral pharmaceutical compositions and methods |
| US10702485B2 (en) | 2011-07-09 | 2020-07-07 | Syntrix Biosystems Inc. | Compositions and methods for overcoming resistance to tramadol |
-
2012
- 2012-07-08 US US13/543,883 patent/US10702485B2/en active Active
- 2012-07-09 LT LTEP12810860.2T patent/LT2729134T/lt unknown
- 2012-07-09 EP EP17172870.2A patent/EP3272339A1/en not_active Withdrawn
- 2012-07-09 EP EP12810860.2A patent/EP2729134B1/en active Active
- 2012-07-09 ES ES12810860.2T patent/ES2650368T3/es active Active
- 2012-07-09 RS RS20171178A patent/RS56570B1/sr unknown
- 2012-07-09 HU HUE12810860A patent/HUE037341T2/hu unknown
- 2012-07-09 DK DK12810860.2T patent/DK2729134T3/en active
- 2012-07-09 PT PT128108602T patent/PT2729134T/pt unknown
- 2012-07-09 PL PL12810860T patent/PL2729134T3/pl unknown
- 2012-07-09 WO PCT/US2012/045885 patent/WO2013009666A1/en active Application Filing
- 2012-07-09 SI SI201231115T patent/SI2729134T1/sl unknown
-
2013
- 2013-04-05 NO NO13728551A patent/NO2833973T3/no unknown
-
2015
- 2015-08-07 US US14/821,506 patent/US9808432B2/en active Active
- 2015-11-23 US US14/949,434 patent/US9717700B2/en active Active
-
2016
- 2016-04-06 US US15/092,533 patent/US9717701B2/en active Active
-
2017
- 2017-07-27 US US15/662,160 patent/US20170319510A1/en not_active Abandoned
- 2017-07-27 US US15/662,189 patent/US20170319511A1/en not_active Abandoned
- 2017-11-08 CY CY20171101169T patent/CY1119597T1/el unknown
- 2017-11-13 HR HRP20171743TT patent/HRP20171743T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10702485B2 (en) | 2020-07-07 |
| WO2013009666A1 (en) | 2013-01-17 |
| RS56570B1 (sr) | 2018-02-28 |
| US20150342905A1 (en) | 2015-12-03 |
| DK2729134T3 (en) | 2017-10-09 |
| US9717700B2 (en) | 2017-08-01 |
| US20130011444A1 (en) | 2013-01-10 |
| EP2729134A1 (en) | 2014-05-14 |
| HUE037341T2 (hu) | 2018-08-28 |
| HRP20171743T1 (hr) | 2017-12-29 |
| EP2729134B1 (en) | 2017-08-23 |
| US20170319511A1 (en) | 2017-11-09 |
| PT2729134T (pt) | 2017-11-24 |
| US20160220514A1 (en) | 2016-08-04 |
| PL2729134T3 (pl) | 2018-01-31 |
| US20160074341A1 (en) | 2016-03-17 |
| EP3272339A1 (en) | 2018-01-24 |
| US9808432B2 (en) | 2017-11-07 |
| EP2729134A4 (en) | 2015-03-04 |
| ES2650368T3 (es) | 2018-01-18 |
| LT2729134T (lt) | 2017-10-10 |
| US20170319510A1 (en) | 2017-11-09 |
| US9717701B2 (en) | 2017-08-01 |
| SI2729134T1 (sl) | 2017-12-29 |
| CY1119597T1 (el) | 2018-04-04 |